About


The Division of Cognitive Neuroscience (DCN) at the University of Basel was founded in 2009 to promote interdisciplinary research in the field of cognitive neuroscience. The DCN is affiliated both with the Faculty of Psychology and with the Faculty of Medicine (University Psychiatric Clinics) and headed by Professor Dominique de Quervain. In the field of cognitive genetics, the DCN has strong collaboration with the Division of Molecular Neuroscience at the University of Basel. Scientists at the DCN have backgrounds in a variety of disciplines, including psychiatry, psychology, pharmacology, genetics, neuroimaging and bioinformatics.






NEWS >>>  01/12







NEWS >>>  03/11



 












NEWS >>>  11/10






NEWS >>>  10/10


SINERGIA: Start of the collaborative research project Emotional Memory in Health and Disease funded by the Swiss National Science Foundation


    -> details




NEWS >>>  08/10


The European Space Agency selects an international project, which investigates the consequences of stress in space for the immune system and the brain. The DCN focuses on stress effects on memory.


NASA/courtesy of www.nasaimages.org




NEWS >>>  11/09











 

Copyright © Division of Cognitive Neuroscience

Larry R. Squire receives Honorary Doctorate from the University of Basel in recognition of his pioneering contributions to the field of learning and memory.

Read more about Larry Squire ->



Glucocorticoids enhance extinction-based psychotherapy.pdf

-> NEWS in Science

see commentary in PNAS:
Healing anxiety disorders 
with glucocorticoids.pdf




unibas-dcn_files/PNAS-2011-1018214108.pdfhttp://news.sciencemag.org/sciencenow/2011/03/damping-down-fear-with-cortisol.html?ref=hpunibas-dcn_files/Healing%20anxiety%20disorders%20with%20glucocorticoids.pdfunibas-dcn_files/Healing%20anxiety%20disorders%20with%20glucocorticoids.pdfhttp://psycho.unibas.ch/abteilungen/abteilung-details/home/abteilung/molecular-psychology/shapeimage_12_link_0shapeimage_12_link_1shapeimage_12_link_2shapeimage_12_link_3

New project „Human genetics-driven discovery of memory-modulating drugs“ with the biopharmaceutical company

AC IMMUNE. This project is partially funded by the the Commission for Technology and Innovation (CTI) of the Federal Department of Economic Affairs.